{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:11:09Z","timestamp":1780719069227,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PC210168"],"award-info":[{"award-number":["PC210168"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PC210168"],"award-info":[{"award-number":["PC210168"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2001098"],"award-info":[{"award-number":["APP2001098"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2001098"],"award-info":[{"award-number":["APP2001098"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002337","name":"Petre Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001325","name":"Cancer Association of South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Serum testosterone levels decrease in the aging male, while the risk for prostate cancer (PCa) increases concomitantly. Higher levels in younger men have been linked with racially driven PCa disparities, with African men disproportionately impacted. In turn, higher levels of serum lipids have been associated with aggressive disease, while racial disparity between serum testosterone, cholesterol and cancer mortality has been suggested. Having previously reported a 2.1-fold increased age-adjusted risk for aggressive PCa in Black South African over Black American men, we determined the serum testosterone and associated lipid levels in 250 Black South African men either with or without clinicopathologically diagnosed disease. Observing no associations with serum lipid levels, Black South Africans presented with testosterone levels between 1.24 (&lt;\u200960 years) and 1.3-fold (\u2265\u200960 years) greater than Black Americans. Notably, a rapid drop in total-, bioavailable- and free testosterone levels in men 65 years or older was significantly associated with PCa risk (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.0057, 0.009 and 0.005, respectively), while irrespective of age, further associated with advanced disease (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.004, 0.0012 and 0.0036, respectively). These preliminary data provide insights into the potential role of androgens in driving PCa health disparities, with important consequence for tailoring treatment for Black men.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-92539-y","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T09:52:26Z","timestamp":1744105946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associating serum testosterone levels with African ancestral prostate cancer health disparities"],"prefix":"10.1038","volume":"15","author":[{"given":"Maphuti Tebogo","family":"Lebelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naledi","family":"Mmekwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Louw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerachai","family":"Jaratlerdsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingai B. A.","family":"Mutambirwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Loda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S. Riana","family":"Bornman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"92539_CR1","doi-asserted-by":"crossref","unstructured":"Bigler, S. A., Pound, C. R. & Zhou, X. A retrospective study on pathologic features and racial disparities in prostate cancer. Prostate Cancer 2011, e239460 (2011).","DOI":"10.1155\/2011\/239460"},{"key":"92539_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics. CA Cancer J. Clin. 72, 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"92539_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.eururo.2016.05.011","volume":"71","author":"SP Kelly","year":"2017","unstructured":"Kelly, S. P. et al. Trends in the incidence of fatal prostate cancer in the united States by race. Eur. Urol. 71, 195\u2013201 (2017).","journal-title":"Eur. Urol."},{"key":"92539_CR4","first-page":"1","volume":"1","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 1, 1\u201335 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"92539_CR5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/pros.22806","volume":"74","author":"EA Tindall","year":"2014","unstructured":"Tindall, E. A. et al. Clinical presentation of prostate cancer in black South Africans. Prostate 74, 880\u2013891 (2014).","journal-title":"Prostate"},{"key":"92539_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MOU.0000000000000951","volume":"32","author":"SS Nair","year":"2022","unstructured":"Nair, S. S., Chakravarty, D., Dovey, Z. S., Zhang, X. & Tewari, A. K. Why do African-American men face higher risks for lethal prostate cancer? Curr. Opin. Urol. 32, 96\u2013101 (2022).","journal-title":"Curr. Opin. Urol."},{"key":"92539_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41586-022-05154-6","volume":"609","author":"W Jaratlerdsiri","year":"2022","unstructured":"Jaratlerdsiri, W. et al. African-specific molecular taxonomy of prostate cancer. Nature 609, 552\u2013559 (2022).","journal-title":"Nature"},{"key":"92539_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.eururo.2023.04.006","volume":"84","author":"PX Soh","year":"2023","unstructured":"Soh, P. X. & Hayes, V. M. Common genetic variants associated with prostate cancer risk: the need for African inclusion. Eur. Urol. 84, 22\u201324 (2023).","journal-title":"Eur. Urol."},{"key":"92539_CR9","doi-asserted-by":"publisher","first-page":"8037","DOI":"10.1038\/s41467-023-43726-w","volume":"14","author":"PX Soh","year":"2023","unstructured":"Soh, P. X. et al. Prostate cancer genetic risk and associated aggressive disease in men of African ancestry. Nat. Commun. 14, 8037 (2023).","journal-title":"Nat. Commun."},{"key":"92539_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/13685538.2018.1524456","volume":"22","author":"A Yassin","year":"2019","unstructured":"Yassin, A., AlRumaihi, K., Alzubaidi, R., Alkadhi, S. & Ansari, A. Testosterone, testosterone therapy and prostate cancer. Aging Male 22, 219\u2013227 (2019).","journal-title":"Aging Male"},{"key":"92539_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.juro.2014.07.123","volume":"193","author":"J Klap","year":"2015","unstructured":"Klap, J., Schmid, M. & Loughlin, K. R. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy. J. Urol. 193, 403\u2013414 (2015).","journal-title":"J. Urol."},{"key":"92539_CR12","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1097\/JU.0000000000002440","volume":"207","author":"M Shahait","year":"2022","unstructured":"Shahait, M. et al. Does perioperative testosterone predict post-prostatectomy genomic risk score? J. Urol. 207, 1214\u20131221 (2022).","journal-title":"J. Urol."},{"key":"92539_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.eururo.2009.03.088","volume":"56","author":"H Isbarn","year":"2009","unstructured":"Isbarn, H. et al. Testosterone and prostate cancer: revisiting old paradigms. Eur. Urol. 56, 48\u201356 (2009).","journal-title":"Eur. Urol."},{"key":"92539_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4103\/1008-682X.148067","volume":"17","author":"A Morgentaler","year":"2015","unstructured":"Morgentaler, A. & Conners, W. P. III Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations. Asian J. Androl. 17, 206\u2013211 (2015).","journal-title":"Asian J. Androl."},{"key":"92539_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/ijc.34116","volume":"151","author":"EL Watts","year":"2022","unstructured":"Watts, E. L. et al. Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia. Int. J. Cancer 151, 1033\u20131046 (2022).","journal-title":"Int. J. Cancer"},{"key":"92539_CR16","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1158\/1055-9965.EPI-04-0715","volume":"14","author":"JK Parsons","year":"2005","unstructured":"Parsons, J. K. et al. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol. Biomark. Prev. 14, 2257\u20132260 (2005).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"92539_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/j.1464-410X.2009.08853.x","volume":"105","author":"PM Pierorazio","year":"2010","unstructured":"Pierorazio, P. M. et al. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore longitudinal study of aging. BJU Int. 105, 824\u2013829 (2010).","journal-title":"BJU Int."},{"key":"92539_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jsxm.2022.01.003","volume":"19","author":"JM Flores","year":"2022","unstructured":"Flores, J. M. et al. The relationship between PSA and total testosterone levels in men with prostate cancer. J. Sex. Med. 19, 471\u2013478 (2022).","journal-title":"J. Sex. Med."},{"key":"92539_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/CIA.S190","volume":"3","author":"RD Stanworth","year":"2008","unstructured":"Stanworth, R. D. & Jones, T. H. Testosterone for the aging male; current evidence and recommended practice. Clin. Interv. Aging 3, 25\u201344 (2008).","journal-title":"Clin. Interv. Aging"},{"key":"92539_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4103\/1008-682X.174856","volume":"19","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Dai, B. & Ye, D. W. Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients. Asian J. Androl. 19, 178\u2013183 (2017).","journal-title":"Asian J. Androl."},{"key":"92539_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ncpuro1296","volume":"6","author":"WP Harris","year":"2009","unstructured":"Harris, W. P., Mostaghel, E. A., Nelson, P. S. & Montgomery, B. Androgen deprivation therapy: progress in Understanding mechanisms of resistance and optimizing androgen depletion. Nat. Clin. Pract. Urol. 6, 76\u201385 (2009).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"92539_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2605.2011.01230.x","volume":"35","author":"SJ Nyante","year":"2012","unstructured":"Nyante, S. J. et al. Trends in sex hormone concentrations in US males: 1988\u20131991 to 1999\u20132004. Int. J. Androl. 35, 456\u2013466 (2012).","journal-title":"Int. J. Androl."},{"key":"92539_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10552-013-0154-8","volume":"24","author":"DS Lopez","year":"2013","unstructured":"Lopez, D. S. et al. Racial\/ethnic differences in serum sex steroid hormone concentrations in US adolescent males. Cancer Causes Control 24, 817\u2013826 (2013).","journal-title":"Cancer Causes Control"},{"key":"92539_CR24","first-page":"67","volume":"2","author":"H Hu","year":"2015","unstructured":"Hu, H., Odedina, F. T., Reams, R. R., Lissaker, C. T. & Xu, X. Racial differences in age-related variations of testosterone levels among US males: potential implications for prostate cancer and personalized medication. J. Racial Ethn. Health Disparities 2, 67\u201376 (2015).","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"92539_CR25","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0090-4295(99)00290-3","volume":"54","author":"III Kubricht","year":"1999","unstructured":"Kubricht, I. I. I., Williams, W. S., Whatley, B. J., Pinckard, T. & Eastham, P. Serum testosterone levels in African-American and white men undergoing prostate biopsy. Urology 54, 1035\u20131038 (1999).","journal-title":"Urology"},{"key":"92539_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/metabo13020284","volume":"13","author":"S Ramakrishnan","year":"2023","unstructured":"Ramakrishnan, S. et al. Serum androgen metabolites correlate with clinical variables in African and European American men with localized, therapy Na\u00efve prostate cancer. Metabolites 13, 284 (2023).","journal-title":"Metabolites"},{"key":"92539_CR27","doi-asserted-by":"publisher","first-page":"47110","DOI":"10.18632\/oncotarget.16943","volume":"8","author":"TJ Schnoeller","year":"2017","unstructured":"Schnoeller, T. J., Jentzmik, F., Schrader, A. J. & Steinestel, J. Influence of serum cholesterol level and Statin treatment on prostate cancer aggressiveness. Oncotarget 8, 47110\u201347120 (2017).","journal-title":"Oncotarget"},{"key":"92539_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41391-017-0030-9","volume":"21","author":"J Jamnagerwalla","year":"2018","unstructured":"Jamnagerwalla, J. et al. Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study. Prostate Cancer Prostatic Dis. 21, 252\u2013259 (2018).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"92539_CR29","doi-asserted-by":"publisher","first-page":"155798832091878","DOI":"10.1177\/1557988320918788","volume":"14","author":"H Hirano","year":"2020","unstructured":"Hirano, H. et al. Impact of pretreatment total cholesterol level is associated with metastasis of prostate cancer. Am. J. Mens Health. 14, 1557988320918788 (2020).","journal-title":"Am. J. Mens Health"},{"key":"92539_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1158\/1055-9965.EPI-15-0876","volume":"25","author":"EH Allott","year":"2016","unstructured":"Allott, E. H. et al. Racial differences in the association between preoperative serum cholesterol and prostate cancer recurrence: results from the SEARCH database. Cancer Epidemiol. Biomark. Prev. 25, 547\u2013554 (2016).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"92539_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s42000-022-00360-3","volume":"21","author":"DS Lopez","year":"2022","unstructured":"Lopez, D. S. et al. Low testosterone and high cholesterol levels in relation to all-cause, cardiovascular disease, and cancer mortality in white, black, and Hispanic men: NHANES 1988\u20132015. Hormones 21, 399\u2013411 (2022).","journal-title":"Hormones"},{"key":"92539_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12944-023-01928-7","volume":"22","author":"GK Gomes","year":"2023","unstructured":"Gomes, G. K. et al. Cholesterol intake and serum total cholesterol levels are not associated with total testosterone levels in men: a cross-sectional study from NHANES 2013\u20132014. Lipids Health Dis. 22, 168 (2023).","journal-title":"Lipids Health Dis."},{"key":"92539_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41391-022-00613-7","volume":"26","author":"M Barlow","year":"2023","unstructured":"Barlow, M. et al. Ethnic differences in prostate-specific antigen levels in men without prostate cancer: A systematic review. Prostate Cancer Prostatic Dis. 26, 249\u2013456 (2023).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"92539_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1200\/JCO.2003.02.083","volume":"21","author":"SP Balk","year":"2003","unstructured":"Balk, S. P., Ko, Y. J. & Bubley, G. J. Biology of prostate-specific antigen. J. Clin. Oncol. 21, 383\u2013391 (2003).","journal-title":"J. Clin. Oncol."},{"key":"92539_CR35","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/pros.23069","volume":"75","author":"D Zapata","year":"2015","unstructured":"Zapata, D. et al. Is PSA related to serum cholesterol and does the relationship differ between black and white men? Prostate 75, 1877\u20131885 (2015).","journal-title":"Prostate"},{"key":"92539_CR36","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J. & Blackman, M. R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J. Clin. Endocrinol. Metab. 86, 724\u2013731 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"92539_CR37","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ucl.2022.07.007","volume":"49","author":"PJ Snyder","year":"2022","unstructured":"Snyder, P. J. What we have learned from the testosterone trials. Urol. Clin. N. Am. 49, 637\u2013644 (2022).","journal-title":"Urol. Clin. N. Am."},{"key":"92539_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/ajhb.22482","volume":"26","author":"L Xu","year":"2014","unstructured":"Xu, L., Yeung, A., Kavikondala, S. L., Leung, S. & Schooling, G. M. Testosterone concentrations in young healthy US. Chin. Men Am. J. Hum. Biol. 26, 99\u2013102 (2014).","journal-title":"Chin. Men Am. J. Hum. Biol."},{"key":"92539_CR39","doi-asserted-by":"publisher","first-page":"e2144027","DOI":"10.1001\/jamanetworkopen.2021.44027","volume":"5","author":"K Yamoah","year":"2022","unstructured":"Yamoah, K. et al. Racial and ethnic disparities in prostate cancer outcomes in the veterans affairs health care system. JAMA Netw. Open 5, e2144027 (2022).","journal-title":"JAMA Netw. Open"},{"key":"92539_CR40","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1464-410X.2010.09685.x","volume":"107","author":"EM Raymundo","year":"2011","unstructured":"Raymundo, E. M., Rice, K. R., Chen, Y., Zhao, J. & Brassell, S. A. Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system. BJU Int. 107, 1216\u20131222 (2011).","journal-title":"BJU Int."},{"key":"92539_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2407-12-25","volume":"12","author":"K Shafique","year":"2012","unstructured":"Shafique, K. et al. Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years\u2019 follow up. BMC Cancer 12, 25 (2012).","journal-title":"BMC Cancer"},{"key":"92539_CR42","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/s12885-016-2691-5","volume":"16","author":"T Heir","year":"2016","unstructured":"Heir, T. et al. Cholesterol and prostate cancer risk: a long-term prospective cohort study. BMC Cancer 16, 643 (2016).","journal-title":"BMC Cancer"},{"key":"92539_CR43","doi-asserted-by":"publisher","first-page":"e23705","DOI":"10.1002\/jcla.23705","volume":"35","author":"MM Garrido","year":"2021","unstructured":"Garrido, M. M., Marta, J. C., Ribeiro, R. M., Pinheiro, L. C. & Guimar\u00e3es, J. T. Serum lipids and prostate cancer. J. Clin. Lab. Anal. 35, e23705 (2021).","journal-title":"J. Clin. Lab. Anal."},{"key":"92539_CR44","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/cam4.665","volume":"5","author":"R Arthur","year":"2016","unstructured":"Arthur, R. et al. Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories. Cancer Med. 5, 1307\u20131318 (2016).","journal-title":"Cancer Med."},{"key":"92539_CR45","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1002\/cncr.27677","volume":"118","author":"C H\u00e4ggstr\u00f6m","year":"2012","unstructured":"H\u00e4ggstr\u00f6m, C. et al. Prospective study on metabolic factors and risk of prostate cancer. Cancer 118, 6199\u20136206 (2012).","journal-title":"Cancer"},{"key":"92539_CR46","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/nu14071325","volume":"14","author":"C Wei","year":"2022","unstructured":"Wei, C. et al. Association between serum triglycerides and prostate specific antigen (PSA) among U.S. Males: National health and nutrition examination survey (NHANES), 2003\u20132010. Nutrients 14, 1325 (2022).","journal-title":"Nutrients"},{"key":"92539_CR47","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/1097-0142(19811115)48:10<2267::AID-CNCR2820481023>3.0.CO;2-R","volume":"48","author":"B Ahluwalia","year":"1981","unstructured":"Ahluwalia, B. et al. Blood hormone profiles in prostate cancer patients in high-risk and low\u2010risk populations. Cancer 48, 2267\u20132273 (1981).","journal-title":"Cancer"},{"key":"92539_CR48","first-page":"40","volume":"50","author":"M Alsharef","year":"2012","unstructured":"Alsharef, M., Kahie, A., Conradie, M., Goad, E. & Fourie, T. Association between low serum free testosterone and adverse prognostic factors in men diagnosed with prostate cancer in KwaZulu-Natal. S. Afr. J. Surg. 50, 40\u201342 (2012).","journal-title":"S. Afr. J. Surg."},{"key":"92539_CR49","doi-asserted-by":"publisher","first-page":"e0276050","DOI":"10.1371\/journal.pone.0276050","volume":"17","author":"W Mapanga","year":"2022","unstructured":"Mapanga, W. et al. Prevalence of multimorbidity in men of African descent with and without prostate cancer in Soweto, South Africa. PLoS ONE 17, e0276050 (2022).","journal-title":"PLoS ONE"},{"key":"92539_CR50","doi-asserted-by":"publisher","first-page":"20909","DOI":"10.1038\/s41598-023-47993-x","volume":"13","author":"K Gheybi","year":"2023","unstructured":"Gheybi, K. et al. Linking African ancestral substructure to prostate cancer health disparities. Sci. Rep. 13, 20909 (2023).","journal-title":"Sci. Rep."},{"key":"92539_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ajhb.21016","volume":"22","author":"LC Alvarado","year":"2010","unstructured":"Alvarado, L. C. Population differences in the testosterone levels of young men are associated with prostate cancer disparities in older men. Am. J. Hum. Biol. 22, 449\u2013455 (2010).","journal-title":"Am. J. Hum. Biol."},{"key":"92539_CR52","unstructured":"CDC. Questionnaires, Datasets and Related Documentation. http:\/\/www.cdc.gov\/nchs\/nhanes.htm (Accessed 02 May 2022) (CDC, 2013).."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92539-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:23:07Z","timestamp":1744204987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92539-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92539"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92539-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4366943\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12013"}}